Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1482, 2005-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pertuzumab has clinical activity in advanced ovarian cancer
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Access to resources
Recommend
Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. :
Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. :
Docetaxel is active in patients with unresectable metastatic or locally advanced pancreatic cancer
Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. :
First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer
By Gill S.
Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. :